Quantum Genesis AI Corp. (OTC: QGAI), a technology company focused on artificial intelligence, computational modeling, and scientific innovation, issued a statement on March 12, 2026, regarding the Caveat Emptor designation placed on its securities by OTC Markets Group, Inc. on February 12, 2026. The designation, which alerts investors to potential public interest concerns, has prompted the company to seek clarification and initiate a review process.
Since the designation was applied, Quantum Genesis AI has made several attempts to communicate with OTC Markets to understand the basis for the action. OTC Markets indicated that the designation relates to a “public interest concern,” but has not provided further specifics. The company has requested additional clarification and intends to continue cooperating with OTC Markets to address the matter.
OTC Markets recently informed the company that it may formally request a review of the Caveat Emptor designation beginning March 13, 2026. Quantum Genesis AI intends to engage with OTC Markets at the earliest available opportunity to initiate that review process. “We take this matter seriously and are committed to working constructively with OTC Markets to better understand the basis for the designation,” said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. “Our objective is to obtain clarity regarding the matter and to take any appropriate steps necessary as we move through the review process.”
The Caveat Emptor designation is a significant regulatory action that can affect investor confidence and trading liquidity. For a company like Quantum Genesis AI, which is focused on advancing next-generation technologies, addressing such a designation is crucial to maintaining transparency and trust with shareholders. The company’s willingness to cooperate and seek a formal review demonstrates its commitment to resolving the issue.
Quantum Genesis AI Corp. is dedicated to leveraging advanced data-driven tools to support research, discovery, and technology development across emerging sectors. The company maintains a commitment to transparency and responsible corporate governance. For more information, visit the company’s website at www.qgaicorp.com and its profile on OTC Markets at www.otcmarkets.com/stock/QGAI.
The company intends to continue cooperating with OTC Markets and will provide updates as additional information becomes available. This proactive approach may help mitigate any negative impact on the company’s reputation and stock performance. Investors and stakeholders will be watching closely as the review process unfolds.
